We identify, analyse and advise
The Swiss National COVID-19 Science Task Force advises the public authorities in the current COVID-19 crisis. While the Task Force does not make decisions about measures or actions taken, the volunteer group of experts represents relevant scientific fields and ensures that impartial scientific advice is given.
The members of the Swiss National COVID-19 Science Task Force do not receive any remuneration or compensation for their work in the Task Force. Each member has disclosed any potential conflicts of interest. These documents are available on the Organisation & expert groups page.
The transition away from the global pandemic situation may lead to new public health approaches aimed at allowing a fast restart of the economic and social life while controlling the risk transmission of Sars-CoV-2.
Requiring proof of Covid-19 vaccination (Vaccine “Passports” / ”Certificates”): Key ethical, legal, and social issues
Health measures to limit the transmission of SARS-CoV2 aim to protect people against the risk of becoming ill.
Several clinical trials evaluating repurposed or novel drugs for therapy/prevention of Covid-19 have been published since the writing of the first version of this policy brief in August 2020.
Currently, individuals who have been in close contact with a confirmed SARS-CoV-2 case are obliged to go into quarantine until 10 days after the presumed last exposure (here referred to as strategy 0).